Nemoto M, et al. A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain. Arch Virol. 2019 Jun 21.
Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.
See Also:
Latest articles in those days:
- [preprint]Mutational fitness landscapes of diverse human influenza H1N1 neuraminidases 6 hours ago
- [preprint]A modelling challenge to improve preparedness for highly pathogenic avian influenza epidemics: objectives, design and synthetic data generation 6 hours ago
- Influenza A H1N1 Infection Triggers Endothelial Immunothrombosis via TNF-α–Tissue Factor–Thrombin Signaling in Human Brain Microvascular Endothelial Cells 7 hours ago
- Antiviral Susceptibility of Clade 2.3.4.4b H5N1 and H5N5 Influenza Viruses Detected in Birds in Russia During 2021-2022 7 hours ago
- Dairy producers´ perceptions of highly pathogenic avian influenza (HPAI) H5N1 and their influence on implementation of biosecurity changes 1 days ago
[Go Top] [Close Window]


